Abstract: According to one embodiment, an induction motor includes a stator and a rotor. The stator has a stator coil disposed at a stator core having a plurality of stator slots. The rotor has a rotor core rotatably provided with respect to the stator. The rotor core includes a plurality of rotor teeth and a rotor slot formed between the plurality of rotor teeth and having a rotor conductor disposed therein. The rotor teeth include a teeth main body and a flange. The teeth main body extends in a radial direction of the rotor core. The flange extends in a rotating direction of the rotor core from a distal end of the teeth main body. Then, a recessed surface is formed on at least part of an outer circumferential surface of a radial outer side in the flange.

Abstract: A transaxle may include a motor, an input shaft, first and second output shafts, and first and second clutches. The input shaft has first and second ends. The first end of the input shaft is structured to receive an engine power from an engine. The second end of the input shaft is structured to receive motor power from the motor. The first output shaft is driven by power outputted from the input shaft. The second output shaft is driven by the motor power. The second output shaft is extended coaxially to the input shaft. The first clutch is interposed between the motor and the input shaft. The second clutch is interposed between the motor and the second output shaft. The first clutch and the second clutch are coaxially disposed between the second end of the input shaft and an axial end of the second output shaft.

Abstract: A work machine includes a tank that stores liquid. The work machine includes a calculation unit configured to obtain a difference between an amount of the liquid inside the tank acquired at a first timing and an amount of the liquid inside the tank acquired at a second timing after the first timing, and a notification unit configured to notify abnormality information indicating occurrence of abnormality related to the tank in the case where an operating time of the work machine during a period from the first timing to the second timing is equal to or smaller than a first threshold and also the difference is equal to or larger than a second threshold, and further configured not to notify the abnormality information in the case where the operating time is larger than a second threshold.

Abstract: A work machine includes a tank that stores liquid. The work machine includes a calculation unit configured to obtain a difference between an amount of the liquid inside the tank acquired at a first timing and an amount of the liquid inside the tank acquired at a second timing after the first timing, and a notification unit configured to notify abnormality information indicating occurrence of abnormality related to the tank in the case where an operating time of the work machine during a period from the first timing to the second timing is equal to or smaller than a first threshold and also the difference is equal to or larger than a second threshold, and further configured not to notify the abnormality information in the case where the operating time is larger than a second threshold.

Abstract: A speed control method for an automatic transmission includes a first synchronizing process, in which a first clutch portion is operated to be in an engaging state in order to synchronize a first input shaft to a power source, a second synchronizing process, in which the first input shaft is synchronized to the output shaft by operating a gear train connected the first input shaft so as to be in an engaging state, after the first clutch portion is operated so as to be in the disengaging state and a torque transmission path switchover process for switching a torque transmitting path from a second input shaft to the first input shaft by operating the first clutch portion so as to be in an engaging state while the second clutch portion is operated so as to be in an disengaging state.

Abstract: The present invention provides nitrogen-containing fused-ring derivatives represented by the following general formula, or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, in the formula R1 represent H, an optionally substituted alkyl group, an alkenyl group, etc.; R2 represent H, a halogen atom or an alkyl group; R3 and R4 represent H, OH, a halogen atom, an optionally substituted alkyl group, etc.; Y represents CH or N; Q represents alkylene, alkenylene, etc.; ring A represents an aryl group or a heteroaryl group; G represents a group represented by the following general formula (G-1) or (G-2) (in which E1 represents H, F or OH; and E2 represents H, F, a methyl group, etc.

Abstract: A speed control method for an automatic transmission includes a first synchronizing process, in which a first clutch portion is operated to be in an engaging state in order to synchronize a first input shaft to a power source, a second synchronizing process, in which the first input shaft is synchronized to the output shaft by operating a gear train connected the first input shaft so as to be in an engaging state, after the first clutch portion is operated so as to be in the disengaging state and a torque transmission path switchover process for switching a torque transmitting path from a second input shaft to the first input shaft by operating the first clutch portion so as to be in an engaging state while the second clutch portion is operated so as to be in an disengaging state.

Abstract: The present invention provides fused heterocyclic derivatives represented by the general formula: wherein R1 represents H, halogen, OH, etc.; R2 represents H, halogen or an alkyl group; R3 and R4 represent H, OH, halogen, etc.; Q represents alkylene, etc.; ring A represents aryl or heteroaryl; and G represents or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, pharmaceutical compositions comprising the same, and pharmaceutical uses thereof.

Abstract: The present invention provides nitrogen-containing fused-ring derivatives represented by the following general formula, or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, in the formula R1 represent H, an optionally substituted alkyl group, an alkenyl group, etc.; R2 represent H, a halogen atom or an alkyl group; R3 and R4 represent H, OH, a halogen atom, an optionally substituted alkyl group, etc.; Y represents CH or N; Q represents alkylene, alkenylene, etc.; ring A represents an aryl group or a heteroaryl group; G represents a group represented by the following general formula (G-1) or (G-2) (in which E1 represents H, F or OH; and E2 represents H, F, a methyl group, etc.

Abstract: The present invention provides nitrogen-containing fused-ring derivatives represented by the following general formula, or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, in the formula R1 represent H, an optionally substituted alkyl group, analkenyl group, etc.; R2 represent H, a halogen atom or an alkyl group; R3 and R4 represent H, OH, a halogen atom, an optionally substituted alkyl group, etc.; Y represents CH or N; Q represents alkylene, alkenylene, etc.; ring A represents an aryl group or a heteroaryl group; G represents a group represented by the following general formula (G-1) or (G-2) (in which E1 represents H, F or OH; and E2 represents H, F, a methyl group, etc.

Abstract: The present invention provides nitrogen-containing fused-ring derivatives represented by the following general formula, or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, in the formula R1 represent H, an optionally substituted alkyl group, analkenyl group, etc.; R2 represent H, a halogen atom or an alkyl group; R3 and R4 represent H, OH, a halogen atom, an optionally substituted alkyl group, etc.; Y represents CH or N; Q represents alkylene, alkenylene, etc.; ring A represents an aryl group or a heteroaryl group; G represents a group represented by the following general formula (G-1) or (G-2) (in which E1 represents H, F or OH; and E2 represents H, F, a methyl group, etc.

Abstract: In a voice browser apparatus, an HTML document is obtained from a designated URL, the obtained document is analyzed based on a rule designated from a plurality of rules for defining voice input/output contents to fetch voice output contents, voice input candidates and designation information for designating a next object of processing corresponding to each voice input candidate, and the fetched voice output contents are voice-outputted. Then, the voice input from a user for this output is voice-recognized, and controls obtainment of a new document and next analysis based on designation information corresponding to the input candidate matching the recognition result. Thereby, contents for the graphical user interface can easily be browsed using voice input/output.

Abstract: To provide a browser apparatus with the contents of data provided on a network in a form of voice data, voice data indicating a part or the whole of the contents of the data provided on the network is formed and stored on a gateway, on the basis of the data. Data is formed by adding to the data provided on the network an identifier <VOICEOUT . . . > indicating a location where the voice data is stored. This data is provided to the browser apparatus. The browser apparatus receives the voice data from the location indicated by the identifier.

Abstract: The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: wherein R1 is a hydrogen atom or a hydroxyalkyl group; one of Q and T is a group represented by the general formula; the other is an optionally substituted alkyl group or a cycloalkyl group; and R2 is a halogen atom, a hydroxy group, an optionally substituted alkyl group, an optionally substituted alkoxy group, an alkylthio group, a group of the general formula: -A-R3 wherein A is a single bond, an oxygen atom, a methylene group, an ethylene group, —OCH2— or —CH2O—; and R3 is a cycloalkyl group, a heterocycloalkyl group, an optionally substituted aryl group, an optionally substituted tiazolyl group or an optionally substituted pyridyl group, pharmaceutically acceptable salts thereof or prodrugs thereof, which exert an excellent inhibitory activity in human SGLT1, and therefore are useful as drugs for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic

Abstract: This invention has as its object to provide a speech recognition system to which a client and a device that provides a speech recognition process are connected, which provides a plurality of usable speech recognition means to the client, and which allows the client to explicitly switch and use the plurality of speech recognition means connected to the network. To achieve this object, a speech recognition system of this invention has speech input means for inputting speech at the client, designation means for designating one of the plurality of usable speech recognition means, and processing means for making the speech recognition means designated by the designation means recognize speech input from the speech input means.

Abstract: The present invention provides fused heterocyclic derivatives represented by the general formula: wherein R1 represents H, halogen, OH, etc.; R2 represents H, halogen or an alkyl group; R3 and R4 represent H, OH, halogen, etc.; Q represents alkylene, etc.; ring A represents aryl or heteroaryl; and G represents , or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, pharmaceutical compositions comprising the same, and pharmaceutical uses thereof.

Abstract: An information processing apparatus inputs a document having a plurality of input fields, and displays it using a display control item. The apparatus then determines whether or not one of the plurality of input fields is designated by the user. Specific grammar corresponding to the designated input field is selected from a grammar holding unit for holding a plurality of types of grammar, and the selected grammar is used in a speech recognition process.

Abstract: The present invention provides pharmaceutical compositions comprising as an active ingredient a selective SGLT1 inhibitor (e.g., an SGLT1 inhibitor substantially showing no GLUT2 and/or GLUT5 inhibitory effect), which have a wider range of inhibitory effect on carbohydrate absorption and a hypoglycemic effect caused by fructose ingestion at regular diets and therefore can exhibit a marked hypoglycemic effect, and which are suitable as agents for the prevention or treatment of diseases associated with hyperglycemia (e.g., diabetes, impaired glucose tolerance, diabetic complications, obesity).

Abstract: In a sound data setting apparatus for setting an output format of each sound to output sounds corresponding to a plurality of sound data, metadata indicating contents of each sound data is acquired and an output format of a sound concerning the sound data corresponding to the metadata is set on the basis of each metadata.

Abstract: The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: 1